Footer

    Edwyn
    Edwyn

    Conduct a professional comparative analysis in seconds. Empowering your financial decisions with data-driven insights.

    Subscribe to our newsletter

    The latest financial trends, sent to your inbox weekly.

    Products

    • Stock Comparisons
    • Enterprise Value Tool
    • EDGAR Database

    Guides

    • What is Enterprise Value?
    • How much is my company worth?

    Company

    • About
    • Contact us
    • Register

    Legal

    • Privacy
    • Terms

    © Edwyn, LLC. All rights reserved.

    Edwyn logo

    Edwyn

    Contact usWhat is Enterprise Value?Advanced EV Calculator
    Cigna Group (CI)
    Add to EV Report
    Compare CI
    Income
    Balance Sheet
    Edwyn logo

    Edwyn

    Tesla vs GMApple vs MicrosoftNvidia vs AMD
    NVDATSLAAAPL
    EV Demo
    Log in
    Edwyn logo

    Edwyn

    Find Companies
    Find Companies
    EV ReportCompare Stocks
    Companies, tickers…⌘ K
    Try EV demoCompare Stocks
    Log in
    Tesla vs GMApple vs MicrosoftNvidia vs AMD
    EV Demo
    NVDATSLAAAPL
    Log in to save
    Market Cap
    $89B
    Latest price
    $275.39
    1.42%
    Dollar Amounts
    USD (Millions)
    Metric20202021202220232024
    Revenue$160,401$174,078$180,516$195,265$247,121
    Gross Profit$56,917$56,525$55,682$61,464$64,612
    Operating Income$8,153$7,935$8,414$8,536$9,417
    Net Income$8,489$5,415$6,746$5,372$3,778
    Data source10-K10-K10-K10-K10-K
    Showing latest financials
    Data in millions of USD
    Doing some research...

    Commentary on The Cigna Group Performance

    Over the five-year period from 2020 to 2024, The Cigna Group’s revenue shows a clear upward trajectory, growing from approximately 160.4 billion USD in 2020 to 247.1 billion USD in 2024. This represents roughly a 54% increase, with particularly strong revenue growth observed in 2024 following a steady rise in previous years. Gross profit, while less volatile, moved from 56.9 billion USD in 2020 to 64.6 billion USD in 2024, indicating a modest improvement in profitability despite the larger revenue gains. Operating income has remained relatively stable, hovering between 7.9 billion and 9.4 billion USD, which suggests that the company has managed to maintain controlled operating expenses even as its top-line numbers increased. However, net income trends paint a different picture. Despite the revenue and operating income gains, net income declined from 8.5 billion USD in 2020 to 3.8 billion USD in 2024, marking significant year-over-year swings, including a notable drop of over 20% from 2023 (net income of 5.4 billion USD) to 2024. This downtrend in net income could indicate rising non-operating expenses, changes in tax rates, or increased claims and regulatory costs that are prevalent within the health insurance industry. Overall, while the company’s robust revenue growth and stable operating income reflect solid operational performance, the declining net income raises concerns about profitability and efficiency. This mixed performance calls for closely monitoring cost management and external factors affecting bottom-line outcomes to ensure long-term financial sustainability.

    This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.